164 related articles for article (PubMed ID: 31646927)
1. Physician Renewal of Chronically Prescribed Controlled Substances Based on Urine Drug Test Results.
Hosain F; Lee J; Ata A; Bhullar RK; Chang AK
J Prim Care Community Health; 2019; 10():2150132719883632. PubMed ID: 31646927
[No Abstract] [Full Text] [Related]
2. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
[TBL] [Abstract][Full Text] [Related]
3. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
4. Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified.
Wyse JJ; Morasco BJ; Dobscha SK; Demidenko MI; Meath THA; Lovejoy TI
J Opioid Manag; 2018; 14(4):295-303. PubMed ID: 30234926
[TBL] [Abstract][Full Text] [Related]
5. Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain.
Morasco BJ; Krebs EE; Adams MH; Hyde S; Zamudio J; Dobscha SK
Clin J Pain; 2019 Jan; 35(1):1-6. PubMed ID: 30222612
[TBL] [Abstract][Full Text] [Related]
6. Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database.
Saloner B; Whitley P; LaRue L; Dawson E; Huskey A
JAMA Netw Open; 2021 Sep; 4(9):e2123019. PubMed ID: 34505888
[TBL] [Abstract][Full Text] [Related]
7. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
[TBL] [Abstract][Full Text] [Related]
8. Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain?
Larochelle MR; Cruz R; Kosakowski S; Gourlay DL; Alford DP; Xuan Z; Krebs EE; Yan S; Lasser KE; Samet JH; Liebschutz JM
J Gen Intern Med; 2022 Aug; 37(10):2365-2372. PubMed ID: 34405344
[TBL] [Abstract][Full Text] [Related]
9. Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.
Turner JA; Saunders K; Shortreed SM; Rapp SE; Thielke S; LeResche L; Riddell KM; Von Korff M
J Gen Intern Med; 2014 Feb; 29(2):305-11. PubMed ID: 24142119
[TBL] [Abstract][Full Text] [Related]
10. Shorter drug testing intervals are associated with improved drug misuse rates.
Gudin J; Mehta N; McClure FL; Niles JK; Kaufman HW
J Opioid Manag; 2020 Sep/Oct 2020; 16(5):357-373. PubMed ID: 33226093
[TBL] [Abstract][Full Text] [Related]
11. Correlates of opioid and benzodiazepine co-prescription among people living with HIV in British Columbia, Canada: A population-level cohort study.
Parent S; Nolan S; Fairbairn N; Ye M; Wu A; Montaner J; Barrios R; Ti L;
Int J Drug Policy; 2019 May; 67():52-57. PubMed ID: 30897373
[TBL] [Abstract][Full Text] [Related]
12. Definitive urine drug test findings in patients prescribed opioids for pain from a large national database.
Guevara MG; LaRue L; Zacharoff KL; Whitley P; Dawson E; Passik SD
J Opioid Manag; 2022; 18(4):361-375. PubMed ID: 36052933
[TBL] [Abstract][Full Text] [Related]
13. Role of urine toxicology testing in the management of chronic opioid therapy.
Katz N; Fanciullo GJ
Clin J Pain; 2002; 18(4 Suppl):S76-82. PubMed ID: 12479257
[TBL] [Abstract][Full Text] [Related]
14. Using Urine Drug Testing to Estimate the Prevalence of Drug Use : Lessons Learned From the New York City Health and Nutrition Examination Survey, 2013-2014.
Han BH; Mello E; Tuazon E; Paone D
Public Health Rep; 2021; 136(1):47-51. PubMed ID: 33108963
[TBL] [Abstract][Full Text] [Related]
15. Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests.
Bagley SM; Cheng DM; Winter M; Alford DP; LaBelle C; Walley AY; Samet JH
Drug Alcohol Depend; 2018 Nov; 192():245-249. PubMed ID: 30290291
[TBL] [Abstract][Full Text] [Related]
16. Urine Drug Test Results Among Adolescents and Young Adults in an Outpatient Office-Based Opioid Treatment Program.
Ramey OL; Bonny AE; Silva Almodóvar A; Nahata MC
J Adolesc Health; 2023 Jul; 73(1):141-147. PubMed ID: 37031090
[TBL] [Abstract][Full Text] [Related]
17. Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic.
Arthur JA; Edwards T; Lu Z; Reddy S; Hui D; Wu J; Liu D; Williams JL; Bruera E
Cancer; 2016 Dec; 122(23):3732-3739. PubMed ID: 27509305
[TBL] [Abstract][Full Text] [Related]
18. Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results.
Turner JA; Saunders K; Shortreed SM; LeResche L; Riddell K; Rapp SE; Von Korff M
J Gen Intern Med; 2014 Dec; 29(12):1663-71. PubMed ID: 25217208
[TBL] [Abstract][Full Text] [Related]
19. Predictors of higher-risk chronic opioid prescriptions in an academic primary care setting.
Bauer SR; Hitchner L; Harrison H; Gerstenberger J; Steiger S
Subst Abus; 2016; 37(1):110-7. PubMed ID: 26848633
[TBL] [Abstract][Full Text] [Related]
20. Repeated Quantitative Urine Toxicology Analysis May Improve Chronic Pain Patient Compliance with Opioid Therapy.
Knezevic NN; Khan OM; Beiranvand A; Candido KD
Pain Physician; 2017 Feb; 20(2S):S135-S145. PubMed ID: 28226335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
